Janus kinase inhibitors are potential therapeutics for amyotrophic lateral sclerosis

Peter J. Richardson; Daniel P. Smith; Alex de Giorgio; Xenia Snetkov; Joshua Almond-Thynne; Sara Cronin; Richard J. Mead; Christopher J. McDermott; Pamela J. Shaw

doi:10.1186/s40035-023-00380-y

Peter J. Richardson, Daniel P. Smith, Alex de Giorgio, Xenia Snetkov, Joshua Almond-Thynne, Sara Cronin, Richard J. Mead, Christopher J. McDermott, Pamela J. Shaw

Translational Neurodegeneration ›› 2023, Vol. 12 ›› Issue (0) : 47.

PDF(1222 KB)

Translational Neurodegeneration ›› 2023, Vol. 12 ›› Issue (0) : 47. DOI: 10.1186/s40035-023-00380-y

Review

Janus kinase inhibitors are potential therapeutics for amyotrophic lateral sclerosis

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2023, 12(0): 47 https://doi.org/10.1186/s40035-023-00380-y

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(1222 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Accepted	Published
2023-07-13	2023-10-03	2023-01-01
Issue Date
2023-10-12

Please choose a citation manager

Content to export